Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Calcium-binding protein 1 (CABP1) is a calcium-binding, neuron-specific regulatory protein belonging to the calmodulin superfamily. It contains four EF-hand motifs and modulates activity of multiple calcium channels and receptors, including L-type and P/Q-type voltage-gated calcium channels, inositol 1,4,5-triphosphate receptors, and TRPC5 channels[1][2][4][5]. CABP1 regulates neuronal calcium signaling, thereby influencing synaptic transmission, cellular excitability, and protection against excitotoxic degeneration. It exists in several isoforms (e.g., caldendrin), with differential subcellular localization in neurons and sensory cells[2]. CABP1 expression is highest in the retina and brain, notably in the hippocampus, cortex, amacrine, and cone bipolar cells[1][2]. While not a direct therapeutic target, CABP1 has been implicated in brain tumor prognosis and may influence neurological disease due to its role in calcium homeostasis[2][4].
CABP1 itself does not have drugs directly targeting it; drugs acting on L-type or P/Q-type calcium channels, or InsP3 receptors, may be indirectly influenced by CABP1 if it alters channel gating
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Calcium-binding protein 1 (CABP1).